Methods-of-use patents have quietly become the pharmaceutical industry’s most underappreciated exclusivity tool. Here’s how they work, who’s using them, and […]

The Window You Cannot Miss Every drug patent that expires is a commercial event for at least a dozen industries.

The FDA lets you extend only one patent per drug approval. Most companies leave years of exclusivity on the table

There is a persistent gap between what Western pharmaceutical executives think they know about drug patent protection in Eurasia and

A Strategic Guide for Pharmaceutical IP Professionals, Formulation Scientists, and Generic Drug Developers Introduction: Why Patent Claims Decide Who Wins

Every pharmaceutical patent starts its life with a 20-year timer running from the filing date. By the time a new

Every patent portfolio in the pharmaceutical industry contains dead weight. Not metaphorically — literally. Compounds whose commercial logic evaporated years

Launching a drug without a freedom-to-operate analysis is like building a factory on land you haven’t verified you own. You

How to Win Biopharma Contracts by Entering the Deal Before Generic Entry Does Why Timing Is the Only Thing That